Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 10,066Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Promacta

02 8Promacta/Revolade

03 5Revolade/Promacta

PharmaCompass

01

Brand Name : Promacta/Revolade

Eltrombopag

arrow
Antibody Engineering
Not Confirmed

Brand Name : Promacta/Revolade

arrow
Antibody Engineering
Not Confirmed

Eltrombopag

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 1,738

2019 Revenue in Millions : 1,416

Growth (%) : 23

blank

02

Brand Name : Promacta/Revolade

Eltrombopag Olamine

arrow
Antibody Engineering
Not Confirmed

Brand Name : Promacta/Revolade

arrow
Antibody Engineering
Not Confirmed

Eltrombopag Olamine

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 1,738

2019 Revenue in Millions : 1,416

Growth (%) : 23

blank

03

Brand Name : Promacta/Revolade

Eltrombopag Olamine

arrow
Antibody Engineering
Not Confirmed

Brand Name : Promacta/Revolade

arrow
Antibody Engineering
Not Confirmed

Eltrombopag Olamine

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 2,016

2020 Revenue in Millions : 1,738

Growth (%) : 16

blank

04

Brand Name : Promacta/Revolade

Eltrombopag

arrow
Antibody Engineering
Not Confirmed

Brand Name : Promacta/Revolade

arrow
Antibody Engineering
Not Confirmed

Eltrombopag

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 2,016

2020 Revenue in Millions : 1,738

Growth (%) : 16

blank

05

Brand Name : Promacta/Revolade

Eltrombopag Olamine

arrow
Antibody Engineering
Not Confirmed

Brand Name : Promacta/Revolade

arrow
Antibody Engineering
Not Confirmed

Eltrombopag Olamine

Main Therapeutic Indication : Hematology

Currency : USD

2022 Revenue in Millions : 2,088

2021 Revenue in Millions : 2,016

Growth (%) : 4

blank

06

Brand Name : Promacta/Revolade

Eltrombopag

arrow
Antibody Engineering
Not Confirmed

Brand Name : Promacta/Revolade

arrow
Antibody Engineering
Not Confirmed

Eltrombopag

Main Therapeutic Indication : Hematology

Currency : USD

2022 Revenue in Millions : 2,088

2021 Revenue in Millions : 2,016

Growth (%) : 4

blank

07

Brand Name : Promacta/Revolade

Eltrombopag Olamine

arrow
Antibody Engineering
Not Confirmed

Brand Name : Promacta/Revolade

arrow
Antibody Engineering
Not Confirmed

Eltrombopag Olamine

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 2,269

2022 Revenue in Millions : 2,088

Growth (%) : 9

blank

08

Brand Name : Promacta/Revolade

Eltrombopag

arrow
Antibody Engineering
Not Confirmed

Brand Name : Promacta/Revolade

arrow
Antibody Engineering
Not Confirmed

Eltrombopag

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 2,269

2022 Revenue in Millions : 2,088

Growth (%) : 9

blank

09

Brand Name : Promacta

EltroMbopag diethanolaMine salt

arrow
Antibody Engineering
Not Confirmed

10

Brand Name : Revolade/Promacta

EltroMbopag diethanolaMine salt

arrow
Antibody Engineering
Not Confirmed

Brand Name : Revolade/Promacta

arrow
Antibody Engineering
Not Confirmed

EltroMbopag diethanolaMine salt

Main Therapeutic Indication : Oncology

Currency : USD

2015 Revenue in Millions : 0

2014 Revenue in Millions : 402

Growth (%) : New Launch

blank